首页> 外文会议>INMM annual meeting >Proliferation Resistance Assessment of Aqueous Homogeneous Solution Reactor for Medical Isotope Production
【24h】

Proliferation Resistance Assessment of Aqueous Homogeneous Solution Reactor for Medical Isotope Production

机译:医用同位素生产水性均相溶液反应器的增殖性抗性评价

获取原文

摘要

Aqueous homogeneous reactor (AHR) has several benefits to be used to produce medical isotopes such as ~(99)Mo, ~(90)Sr, ~(131)I and other fission products. Isotopes as fission products can be direct extracted from the fuel solution after several days of operation. Otherwise AHR has inherent safety characteristics with very large negative reactivity feedback. Assessment in this work was conducted on the AHR with uranyl nitrate solution type AHR with enrichment 19.75% (LEU). Several fissile materials produced by the end of cycle (EOC) were calculated using deterministic method and Monte Carlo Method. The calculation results are used to evaluate the grade of proliferation resistance. The results show, that the consumption of ~(235)U by small burnup power 50 kW is 0.0167% per week. The buildup of plutonium increases proportionally to the burnup time. Total of plutonium buildup in 4 weeks operation is 0.102 g below the significant quantity defined by IAEA. The use of small AHR strengthened by advanced safeguards technologies may improve the proliferation resistance in medical isotope production.
机译:均匀反应器(AHR)具有若干益处,可用于生产医疗同位素,如〜(99)Mo,〜(90)Sr,〜(131)I等裂变产物。随着裂变产品的同位素可以在几天操作后从燃料溶液中直接提取。否则AHR具有具有非常大的负反应性反馈的固有安全性。本作作品中的评估是在AHR中进行的亚硝酸铀酰溶液,浓缩19.75%(Leu)。使用确定性方法和蒙特卡罗方法计算通过循环结束(EOC)产生的几种裂变材料。计算结果用于评估增殖抗性。结果表明,〜(235)U通过小燃烧功率50 kW的消耗为每周0.0167%。钚的积聚与燃尽的时间成比例地增加。 4周运行中的钚积聚总数低于IAEA定义的显着量为0.102克。通过先进的保障技术加强的小AHR的使用可以改善医疗同位素生产中的增殖抗性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号